Quarterly report pursuant to Section 13 or 15(d)

Statements of Cash Flows (Unaudited)

v3.23.2
Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash Flows from Operating Activities:    
Net loss $ (32,928) $ (38,894)
Issuance of common shares - Equity fee on at-the-market offering to Fortress Biotech 0 147
Issuance of common shares - Equity fee on note payable to Fortress Biotech 0 750
Stock-based compensation expenses 280 1,314
Depreciation expense 1,291 1,298
Amortization of debt discount 118 185
Amortization of operating lease right-of-use assets 204 80
Loss on disposal of property and equipment 0 239
Loss on extinguishment of debt 2,796 0
Gain on lease modification (220)  
Prepaid expenses and other assets 325 67
Other receivables - related party 36 17
Accounts payable and accrued expenses (2,022) 1,376
Payable and accrued expenses - related party 5 (275)
Lease liabilities (85) (169)
Net cash used in operating activities (30,200) (33,864)
Cash Flows from Investing Activities:    
Purchase of fixed assets (34) (1,640)
Net cash used in investing activities (34) (1,640)
Cash Flows from Financing Activities:    
Payment of debt (30,375) 0
Proceeds from issuance of common shares - at-the-market offering 0 5,900
Offering costs for the issuance of common shares - at-the-market offering 0 (110)
Proceeds from debt issuance 0 30,000
Fees paid on the issuance of debt 0 (2,651)
Proceeds from issuance of common shares under ESPP 88 116
Net cash provided by financing activities (30,287) 33,255
Net change in cash, cash equivalents and restricted cash (60,521) (2,249)
Cash, cash equivalents and restricted cash, beginning of the period 76,656 110,618
Cash, cash equivalents and restricted cash, end of the period 16,135 108,369
Supplemental disclosure of cash flow information:    
Cash paid for interest 1,340 845
Supplemental disclosure of noncash activities:    
Fixed assets (acquired but not paid) 0 315
Issuance of common shares - Founders Agreement 1,109 4,212
Note payable final payment fee (incurred but not paid) 0 1,050
Issuance of warrants - note payable 0 384
Transfer of assets classified as held for sale $ 4,348 $ 0